Publications by authors named "Michael Ashenden"

Claim this Profile
I
Improved alignment of reticulocyte counts between Sysmex XT-2000i instruments.
Michael Ashenden, Ken Sharpe, James Habel, Anthony Vicentin, Steven Schischka

J Clin Pathol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the MAIIA dipstick test to detect recombinant human erythropoietin in plasma.
Michael Ashenden, Ken Sharpe, Andrew Garnham, Christopher J Gore

J Pharm Biomed Anal· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preanalytical mixing of whole-blood specimens in the context of the Athlete Passport.
Michael Ashenden, Anthea Clarke, Ken Sharpe, Giuseppe d'Onofrio, Graeme Allbon

J Clin Pathol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current markers of the Athlete Blood Passport do not flag microdose EPO doping.
Michael Ashenden, Clare E Gough, Andrew Garnham, Christopher J Gore, Ken Sharpe

Eur J Appl Physiol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of gene expression: help to detect doping with erythropoiesis-stimulating agents.
Emmanuelle Varlet-Marie, Michel Audran, Michael Ashenden, Marie-Thérèse Sicart, David Piquemal

Am J Hematol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications.
Iain C Macdougall, Michael Ashenden

Adv Chronic Kidney Dis· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delta efficiency calculation in Tour de France champion is wrong.
Christopher J Gore, Michael J Ashenden, Ken Sharpe, David T Martin

J Appl Physiol (1985)· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in red blood cell volume, plasma volume, and total blood volume after autologous blood collections.
Jakob Morkeberg, Bo Belhage, Andreas B Rasmussen, Rasmus Damsgaard, Michael J Ashenden

Transfusion· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of microdose recombinant human erythropoietin regimens in athletes.
Michael Ashenden, Emmanuelle Varlet-Marie, Françoise Lasne, Michel Audran

Haematologica· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A third generation approach to detect erythropoietin abuse in athletes.
Ken Sharpe, Michael J Ashenden, Yorck O Schumacher

Haematologica· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments on Point:Counterpoint "Positive effects of intermittent hypoxia (live high:train low) on exercise performance are/are not mediated primarily by augmented red cell volume".
Michael Ashenden

J Appl Physiol (1985)· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal variation of hemoglobin and reticulocytes in elite rowers.
Michael J Ashenden, Alain Lacoste, Emmanuel Orhant, Michel Audran, Ken Sharpe

Haematologica· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary issues in the fight against blood doping in sport.
Michael Ashenden

Haematologica· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes.
Michael J Ashenden, Ken Sharpe, Christian Schoch, Yorck Olaf Schumacher

Haematologica· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doping with artificial oxygen carriers: an update.
Yorck Olaf Schumacher, Michael Ashenden

Sports Med· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of reticulocyte values in an antidoping context.
Michael J Ashenden, Ken Sharpe, Rasmus Damsgaard, Lisa Jarvis

Am J Clin Pathol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: confirmation by size-exclusion HPLC.
Emmanuelle Varlet-Marie, Michael Ashenden, Françoise Lasne, Marie-Therese Sicart, Benedicte Marion

Clin Chem· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: screening by electrophoresis.
Françoise Lasne, Nathalie Crepin, Michael Ashenden, Michel Audran, Jacques de Ceaurriz

Clin Chem· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proof of homologous blood transfusion through quantification of blood group antigens.
Margaret Nelson, Hazel Popp, Ken Sharpe, Michael Ashenden

Haematologica· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.
Michael J Ashenden, Christopher J Gore, Robin Parisotto, Ken Sharpe, Will G Hopkins

Haematologica· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of common hematologic abnormalities on the ability of blood models to detect erythropoietin abuse by athletes.
Robin Parisotto, Michael J Ashenden, Christopher J Gore, Ken Sharpe, Will Hopkins

Haematologica· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-generation blood tests to detect erythropoietin abuse by athletes.
Christopher J Gore, Robin Parisotto, Michael J Ashenden, Jim Stray-Gundersen, Ken Sharpe

Haematologica· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of reference ranges in elite athletes for markers of altered erythropoiesis.
Ken Sharpe, Will Hopkins, Kerry R Emslie, Chris Howe, Graham J Trout, Michael J Ashenden

Haematologica· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of homologous blood transfusion by flow cytometry: a deterrent against blood doping.
Margaret Nelson, Michael Ashenden, Mark Langshaw, Hazel Popp

Haematologica· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise.
Gabrielle Russell, Christopher J Gore, Michael J Ashenden, Robin Parisotto, Allan G Hahn

Eur J Appl Physiol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis